122 related articles for article (PubMed ID: 8738204)
21. [New container of sample: role in the reduction of bacterial contamination of standard platelet units].
Fehri S; Tazi I; Loukhmass L; Benchemsi N
Transfus Clin Biol; 2006 Dec; 13(6):335-40. PubMed ID: 17306583
[TBL] [Abstract][Full Text] [Related]
22. An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts.
Wimperis JZ; Baglin TP; Marcus RE; Warren RE
Bone Marrow Transplant; 1991 Nov; 8(5):363-7. PubMed ID: 1768971
[TBL] [Abstract][Full Text] [Related]
23. Microbial contamination of peripheral blood and bone marrow hematopoietic cell products and environmental contamination in a stem cell bank: a single-center report.
Kozlowska-Skrzypczak M; Bembnista E; Kubiak A; Matuszak P; Schneider A; Komarnicki M
Transplant Proc; 2014 Oct; 46(8):2873-6. PubMed ID: 25380939
[TBL] [Abstract][Full Text] [Related]
24. Bacterial complications of transplantation: diagnosis and treatment.
Donnelly JP
J Antimicrob Chemother; 1995 Oct; 36 Suppl B():59-72. PubMed ID: 8601544
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte-macrophage colony stimulating factor (GM-CSF) as an adjunct to autologous bone marrow transplantation (ABMT) in hematology. Results of the interim analysis of the Schering-Plough/Sandoz International trial and considerations on increased safety in the transplant ward.
Gorin NC; Fouillard L
Pathol Biol (Paris); 1992 Nov; 39(9):954-5. PubMed ID: 1538950
[No Abstract] [Full Text] [Related]
26. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project.
Dettenkofer M; Wenzler-Röttele S; Babikir R; Bertz H; Ebner W; Meyer E; Rüden H; Gastmeier P; Daschner FD;
Clin Infect Dis; 2005 Apr; 40(7):926-31. PubMed ID: 15824981
[TBL] [Abstract][Full Text] [Related]
27. Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation.
Nifong TP; Ehmann WC; Mierski JA; Domen RE; Rybka WB
Arch Pathol Lab Med; 2003 Jan; 127(1):e19-21. PubMed ID: 12562288
[TBL] [Abstract][Full Text] [Related]
28. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Gilbert C; Meisenberg B; Vredenburgh J; Ross M; Hussein A; Perfect J; Peters WP
J Clin Oncol; 1994 May; 12(5):1005-11. PubMed ID: 8164024
[TBL] [Abstract][Full Text] [Related]
29. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients.
Mossad SB; Longworth DL; Goormastic M; Serkey JM; Keys TF; Bolwell BJ
Bone Marrow Transplant; 1996 Aug; 18(2):265-71. PubMed ID: 8864433
[TBL] [Abstract][Full Text] [Related]
30. Microbiologic contamination of peripheral blood stem cell autografts.
Schwella N; Zimmermann R; Heuft HG; Blasczyk R; Beyer J; Rick O; Kreissig C; Zingsem J; Eckstein R; Siegert W
Vox Sang; 1994; 67(1):32-5. PubMed ID: 7975449
[TBL] [Abstract][Full Text] [Related]
31. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations.
Padley D; Koontz F; Trigg ME; Gingrich R; Strauss RG
Transfusion; 1996 Jan; 36(1):53-6. PubMed ID: 8607154
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
[TBL] [Abstract][Full Text] [Related]
33. The origin of coagulase-negative staphylococci isolated from blood cultures.
Viagappan M; Kelsey MC
J Hosp Infect; 1995 Jul; 30(3):217-23. PubMed ID: 8522778
[TBL] [Abstract][Full Text] [Related]
34. The processing of human bone marrow for cryopreservation and reinfusion.
Weiner RS; Tobias JS; Yankee RA
Biomedicine; 1976; 24(4):226-31. PubMed ID: 11006
[TBL] [Abstract][Full Text] [Related]
35. Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates.
Hahn S; Sireis W; Hourfar K; Karpova D; Dauber K; Kempf VA; Seifried E; Schmidt M; Bönig H
Bone Marrow Transplant; 2014 Mar; 49(3):338-48. PubMed ID: 24185589
[TBL] [Abstract][Full Text] [Related]
36. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets.
Yomtovian R; Lazarus HM; Goodnough LT; Hirschler NV; Morrissey AM; Jacobs MR
Transfusion; 1993; 33(11):902-9. PubMed ID: 8259595
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert BM; Morin O; Harousseau JL; Richet H
Clin Infect Dis; 2001 Jul; 33(1):41-7. PubMed ID: 11389493
[TBL] [Abstract][Full Text] [Related]
38. A technique for the concentration of nucleated bone marrow cells for in vitro manipulation or cryopreservation using the IBM 2991 blood cell processor.
Gilmore MJ; Prentice HG; Corringham RE; Blacklock HA; Hoffbrand AV
Vox Sang; 1983; 45(4):294-302. PubMed ID: 6356588
[TBL] [Abstract][Full Text] [Related]
39. [Measures for the prevention of infections in patients with bone marrow transplantations].
Rasero L; Errico A; Bertelli A
Riv Inferm; 1997; 16(3):139-43. PubMed ID: 9460461
[TBL] [Abstract][Full Text] [Related]
40. [Early bacterial infections in 103 patients treated with bone marrow transplantation].
Tomás JF; Hernández LM; Peñarrubia MJ; Figuera A; Jiménez ML; Cámara R; Arranz R; López JL; Cruz J; Fernández-Rañada JM
Sangre (Barc); 1994 Jun; 39(3):191-6. PubMed ID: 7940049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
